Search Results

There are 7704 results for: content related to: Sorafenib use in hepatocellular carcinoma: More questions than answers

  1. You have free access to this content
    Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1111–1121, Adeel R. Seyal, Fernanda D. Gonzalez-Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem and Vahid Yaghmai

    Version of Record online : 19 JUN 2015, DOI: 10.1002/hep.27915

  2. You have free access to this content
    Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 784–791, Massimo Iavarone, Giuseppe Cabibbo, Marco Biolato, Cristina Della Corte, Marcello Maida, Marco Barbara, Michele Basso, Sara Vavassori, Antonio Craxì, Antonio Grieco, Carlo Cammà and Massimo Colombo

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27729

  3. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  4. You have free access to this content
    Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1655–1666, Michael Vouche, Laura Kulik, Rohi Atassi, Khairuddin Memon, Ryan Hickey, Daniel Ganger, Frank H. Miller, Vahid Yaghmai, Michael Abecassis, Talia Baker, Mary Mulcahy, Ritu Nayar, Robert J. Lewandowski and Riad Salem

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26487

  5. You have free access to this content
    Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy

    Hepatology

    Volume 60, Issue 1, July 2014, Pages: 192–201, Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan-Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski and Riad Salem

    Version of Record online : 27 MAY 2014, DOI: 10.1002/hep.27057

  6. mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

    Liver International

    Volume 37, Issue 7, July 2017, Pages: 1047–1055, Tim Meyer, Daniel H. Palmer, Ann-Lii Cheng, Julia Hocke, Arsène-Bienvenu Loembé and Chia-Jui Yen

    Version of Record online : 2 FEB 2017, DOI: 10.1111/liv.13359

  7. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  8. You have free access to this content
    Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

    Hepatology

    Volume 54, Issue 6, December 2011, Pages: 2055–2063, Massimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia, Claudio Zavaglia, Antonio Grieco, Erica Villa, Calogero Cammà, Massimo Colombo and on behalf of the SOFIA (SOraFenib Italian Assessment) study group

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24644

  9. Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography

    Hepatology Research

    Volume 45, Issue 9, September 2015, Pages: 976–985, Hisashi Hidaka, Takahide Nakazawa, Shigeru Fujii, Michiko Yanagihara, Tsutomu Minamino, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Akitaka Shibuya and Wasaburo Koizumi

    Version of Record online : 11 DEC 2014, DOI: 10.1111/hepr.12440

  10. Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib

    Hepatology Research

    Volume 44, Issue 13, December 2014, Pages: 1268–1276, Satoshi Shiba, Takuji Okusaka, Masafumi Ikeda, Hidetsugu Saito and Takafumi Ichida

    Version of Record online : 18 FEB 2014, DOI: 10.1111/hepr.12297

  11. mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib

    International Journal of Cancer

    Volume 140, Issue 2, 15 January 2017, Pages: 390–399, Wenjun Wang, Wei Bai, Enxin Wang, Yan Zhao, Lei Liu, Man Yang, Hongwei Cai, Dongdong Xia, Lei Zhang, Jing Niu, Zhanxin Yin, Zhuoli Zhang, Daiming Fan, Jielai Xia and Guohong Han

    Version of Record online : 17 OCT 2016, DOI: 10.1002/ijc.30451

  12. You have free access to this content
    Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques

    Hepatology

    Volume 54, Issue 6, December 2011, Pages: 2238–2244, Jordi Bruix, Maria Reig, Jordi Rimola, Alejandro Forner, Marta Burrel, Ramón Vilana and Carmen Ayuso

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24670

  13. Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 305–312, Chang Joon Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim and Min-Ji Kim

    Version of Record online : 25 JUL 2013, DOI: 10.1111/liv.12270

  14. Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib

    Hepatology Research

    Volume 44, Issue 13, December 2014, Pages: 1320–1328, Tomokazu Kawaoka, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo and Kazuaki Chayama

    Version of Record online : 24 APR 2014, DOI: 10.1111/hepr.12307

  15. Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation

    Liver Transplantation

    Volume 22, Issue 11, November 2016, Pages: 1491–1500, Marco Dioguardi Burgio, Maxime Ronot, Onorina Bruno, Claire Francoz, Valérie Paradis, Laurent Castera, François Durand, Olivier Soubrane and Valérie Vilgrain

    Version of Record online : 26 OCT 2016, DOI: 10.1002/lt.24615

  16. Serum cell death biomarker mirrors liver cancer regression after transarterial chemoembolisation

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 747–754, B. Bock, D. Hasdemir, F. Wandrer, T. Rodt, M. P. Manns, K. Schulze-Osthoff and H. Bantel

    Version of Record online : 3 AUG 2016, DOI: 10.1111/apt.13758

  17. You have free access to this content
    Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

    Hepatology

    Volume 60, Issue 5, November 2014, Pages: 1697–1707, Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean-Frederic Blanc, Lunan Yan, Jijin Yang, Ligong Lu, Won-Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi-Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian B. Walters, Christine Dela Cruz, Valerie Poulart and Jian-Hua Wang

    Version of Record online : 29 SEP 2014, DOI: 10.1002/hep.27290

  18. You have free access to this content
    Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria

    Hepatology

    Volume 61, Issue 6, June 2015, Pages: 1968–1977, Francis Y. Yao, Neil Mehta, Jennifer Flemming, Jennifer Dodge, Bilal Hameed, Oren Fix, Ryutaro Hirose, Nicholas Fidelman, Robert K. Kerlan Jr. and John P. Roberts

    Version of Record online : 20 MAR 2015, DOI: 10.1002/hep.27752

  19. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study

    Journal of Magnetic Resonance Imaging

    Volume 42, Issue 4, October 2015, Pages: 981–989, Nima Kokabi, Juan C. Camacho, Minzhi Xing, Faramarz Edalat, Pardeep K. Mittal and Hyun S. Kim

    Version of Record online : 12 FEB 2015, DOI: 10.1002/jmri.24845

  20. Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy

    Journal of Surgical Oncology

    Volume 113, Issue 4, March 15, 2016, Pages: 443–448, Olaguoke Akinwande, Prejesh Philips, Charles R. Scoggins, Lawrence Kelly, Cliff Tatum, Mike Hahl, Kelly M. McMasters and Robert C.G. Martin

    Version of Record online : 6 APR 2016, DOI: 10.1002/jso.24141